Elevance Health (ELV) Interest Expenses (2009 - 2026)

Elevance Health (ELV) has 18 years of Interest Expenses data on file, last reported at $580.0 million in Q2 2026.

• On a quarterly basis, Interest Expenses rose 70.09% year-over-year to $580.0 million in Q2 2026; TTM through Jun 2026 was $580.0 million, a 51.59% decrease from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 13.8% from the prior year.
• Interest Expenses for Q2 2026 stood at $580.0 million, down from $611.0 million in the prior quarter.
• Over the last five years, Interest Expenses for ELV reached as high as $2.4 billion in Q3 2023 and fell as low as $201.0 million in Q1 2022.
• Historically, Interest Expenses has averaged $805.1 million across 5 years, with a median of $561.0 million in 2025.
• Across the five-year window, Interest Expenses soared 856.22% in 2023 and plunged 72.96% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $256.0 million in 2022, then advanced by 1.95% to $261.0 million in 2023, then surged by 30.27% to $340.0 million in 2024, then increased by 10.0% to $374.0 million in 2025, then surged by 55.08% to $580.0 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $580.0 million in Q2 2026, $611.0 million in Q1 2026, and $374.0 million in Q4 2025.